| Filed On | Filing |
|---|---|
| 05 Oct 2026 |
Form 3: Gunn Justin Frederick, See Remarks
Holds 12,191 shares of Common Stock |
| 03 Sep 2026 |
Form 3: Vieira Roberto Wandenkolk, President, Oncology
Holds 4,068 shares of Common Stock |
| 19 Aug 2021 |
Form 3: Guyer William, Chief Development Officer
No securities owned |
| 17 Jun 2021 |
Form 3: Murray Joshua M., Director
No securities owned |
| 03 Mar 2021 |
Form 3: Mokari Atabak, Chief Financial Officer
No securities owned |
| 02 Dec 2020 |
Form 3: Cannon Gillian, Director
No securities owned |
| 15 Jul 2020 |
Form 3: Hunt Hazel, Chief Scientific Officer
Holds 200 shares of Common Stock |
| 15 Jul 2020 | Form 3: Lyon Joseph Douglas, Chief Accounting Officer |
| 13 Mar 2020 |
Form 3: Alton Gregg H, Director
No securities owned |
| 18 Sep 2019 |
Form 3: Park Kimberly, Director
No securities owned |
| 01 Apr 2019 |
Form 3: Grauer Andreas, Chief Medical Officer
No securities owned |
| 09 Feb 2018 |
Form 3: Maduck Sean, See Remarks
Holds 10,024 shares of Common Stock |
| 28 Jun 2016 |
Form 3: Gala Renee D, Director
No securities owned |
| 01 Oct 2015 |
Form 3: Fishman Robert S, Chief Medical Officer
No securities owned |
| 22 Jun 2015 |
Form 3: Swisher Daniel N Jr, Director
Holds 0 shares of No securities are beneficially owned |
| 07 Nov 2012 |
Form 3: Pullara Samuel J Iii, 10% owner
Holds 29,273 shares of Common Stock |
| 07 Nov 2012 |
Form 3: Dyckerhoff Stefan A, 10% owner
Holds 29,273 shares of Common Stock |
| 12 Oct 2012 |
Form 3: Bradbury Daniel, Director
No securities owned |
| 12 Sep 2011 |
Form 3: Robb Gary Charles, Chief Financial Officer
Holds 1,258 shares of Common Stock |
| 28 Sep 2010 |
Form 3: Lo Steven, VP Commercial Operations
Holds 0 shares of No securities are beneficially owned |
Loading...